| Prev Close | 7.10 |
| Open | 7.05 |
| Day Low/High | 7.05 / 7.60 |
| 52 Wk Low/High | 6.50 / 24.25 |
| Volume | 143.79K |
| Avg Volume | 842.60K |
| Exchange | NASDAQ |
| Shares Outstanding | 52.51M |
| Market Cap | 122.35M |
| EPS | -2.30 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Cempra Inc . The average 12-month price target for CEMP — averaging the work of 5 analysts — reveals an average price target of $5.60/share.
The most recent short interest data has been released for the 09/29/2017 settlement date, which shows a 1,475,701 share decrease in total short interest for Cempra Inc , to 2,520,168, a decrease of 36.93% since 09/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Axovant shares were up in premarket trading on Sept. 27 after plummeting on Tuesday on the heels of the announcement that the company's Phase 3 study of intepirdine in patients with Alzheimer's disease did not achieve its co-primary efficacy endpoints.
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Cempra Inc . The average 12-month price target for CEMP — averaging the work of 5 analysts — reveals an average price target of $5.60/share.
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Cempra Inc . The average 12-month price target for CEMP — averaging the work of 5 analysts — reveals an average price target of $5.60/share.
And then there is Mylan.
Malin Corporation plc. (ISE:MLC, "Malin"), an Irish based and globally operating life sciences company, today announced that Melinta Therapeutics, Inc.
Management to host webcast and conference call today at 8:45 a.m. ET
Management to host webcast and conference call on Wednesday, August 9, 2017 at 8:45 a.m. ET
The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 581,412 share decrease in total short interest for Cempra Inc , to 4,850,555, a decrease of 10.70% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Management to host webcast and conference call today at 8:45 a.m. ET
—Management to host webcast and conference call on Friday, April 28, 2017 at 8:45 a.m. ET—
Cempra, Tesaro and Editas Medicine were among the biotech stock movers in premarket trading on Tuesday.
—Company plans to resubmit MAA with additional data, in alignment with FDA strategy—
Cempra, Blueprint Medicines and Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Monday.
—Presentation time at Cowen and Company 37th Annual Health Care Conference on Monday, March 6 changed to 2:40 p.m. ET—
Cempra, Novavax and Ionis Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.
